C4X Discovery (LON:C4XD) Stock Price Passes Below 50-Day Moving Average of $11.58

C4X Discovery Holdings plc (LON:C4XDGet Free Report) shares passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 11.58 ($0.14) and traded as low as GBX 8.45 ($0.11). C4X Discovery shares last traded at GBX 9.43 ($0.12), with a volume of 1,612,732 shares.

C4X Discovery Trading Down 3.0 %

The company has a debt-to-equity ratio of 6.49, a quick ratio of 9.82 and a current ratio of 3.28. The company has a 50 day simple moving average of GBX 11.58 and a two-hundred day simple moving average of GBX 12.54. The company has a market cap of £23.05 million, a PE ratio of -235.63 and a beta of 0.27.

Insider Activity at C4X Discovery

In other news, insider Clive Dix acquired 485,320 shares of the company’s stock in a transaction that occurred on Monday, April 8th. The shares were purchased at an average price of GBX 10 ($0.12) per share, for a total transaction of £48,532 ($60,415.78). 24.66% of the stock is currently owned by company insiders.

C4X Discovery Company Profile

(Get Free Report)

C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

Further Reading

Receive News & Ratings for C4X Discovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C4X Discovery and related companies with MarketBeat.com's FREE daily email newsletter.